KA
MET icon

Kearns & Associates’s MetLife MET Stock Holding History

Kearns & Associates’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,000
Closed -$331K – 45
2023
Q4 		$331K Hold
5,000
– – 0.28% 27
2023
Q3 		$315K Hold
5,000
– – 0.3% 25
2023
Q2 		$283K Hold
5,000
– – 0.26% 31
2023
Q1 		$290K Hold
5,000
– – 0.29% 27
2022
Q4 		$362K Buy
+5,000
New +$358K 0.38% 25

Other funds holding MET

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Kearns & Associates's MET Position: Q1 2024 in Review

Kearns & Associates sold out of MetLife (MET) in Q1 2024, closing a stake of 5,000 shares — an estimated $331K sold.

Kearns & Associates first reported a position in MET in Q4 2022 and held it in 5 quarters. The position peaked at $362K in Q4 2022. 1,281 funds tracked by Wall St. Rank hold MET as of Q1 2024.

  • Kearns & Associates reported no remaining MetLife position as of Q1 2024 after selling out during the quarter.
  • Kearns & Associates sold 5,000 MetLife shares in Q1 2024, an estimated $331K.
  • Kearns & Associates first reported a position in MetLife in Q4 2022 and held it in 5 quarters.
  • Kearns & Associates's MetLife position peaked at $362K in Q4 2022.
  • 1,281 funds tracked by Wall St. Rank held MetLife as of Q1 2024.

Based on Kearns & Associates's 13F filing for Q1 2024, filed 10 May 2024.